5-[2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-5-azaspiro[2.4]heptane
Structure Info
- Chemspace ID
- CSSB02533253592 (In-Stock Building Blocks)
- IUPAC Name
- 5-[2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-5-azaspiro[2.4]heptane
- Mol formula
- C20H28BNO3
- Mol weight
- 341 Da
- Catalog Number(s)
- BBLS02533253592, BBV-331915515, EN300-55408752, bbls02533253592
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 4.24
- Heavy atoms count
- 25
- Rotatable bond count
- 2
- Number of rings
- 4
- Carbon bond saturation, Fsp3
- 0.65
- Polar surface area (Å)
- 39
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 0
![Chemical structure of 5-[2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-5-azaspiro[2.4]heptane (C20H28BNO3) - CSSB02533253592](/st/structure/200/3963bd6214ba9afa548273f49df78c54/CC1%253DCC%253DC%2528C%253DC1C%2528%253DO%2529N1CCC2%2528CC2%2529C1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png "C20H28BNO3")
- Zoom the structure
- CSSB02533253592
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 360.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 376.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 393.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 410.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 427.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 838.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 1,240.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 1,839.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of 5-[2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-5-azaspiro[2.3]hexane - CSSB02526926418](/st/structure/200/2b21051515ef81dd2aba753517c55850/CC1%253DCC%253DC%2528C%253DC1C%2528%253DO%2529N1CC2%2528CC2%2529C1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
![Chemical structure of 3,3-dimethyl-1-[2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]pyrrolidine - CSSB02533261526](/st/structure/200/a123977a5d7555ef70b265ae946f372f/CC1%253DCC%253DC%2528C%253DC1C%2528%253DO%2529N1CCC%2528C%2529%2528C%2529C1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
![Chemical structure of 5-[4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-5-azaspiro[2.4]heptane - CSSB02533513499](/st/structure/200/1c71be71ad865542068c9f4f498a0808/CC1%253DCC%253DC%2528C%253DC1B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1%2529C%2528%253DO%2529N1CCC2%2528CC2%2529C1.png)
![Chemical structure of 6-[2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-2-oxa-6-azaspiro[3.3]heptane - CSSB02533248069](/st/structure/200/ef323ab9ab5341d8c4470d03d52877ad/CC1%253DCC%253DC%2528C%253DC1C%2528%253DO%2529N1CC2%2528COC2%2529C1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
![Chemical structure of 5-[3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-5-azaspiro[2.4]heptane - CSSB02533259433](/st/structure/200/75effb1063e4a906be434453a32d8ce8/CC1%253DCC%2528%253DCC%253DC1B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1%2529C%2528%253DO%2529N1CCC2%2528CC2%2529C1.png)
![Chemical structure of 5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-5-azaspiro[2.4]heptane - CSSB02526793764](/st/structure/200/7bfc79e7b9a21346b9848cdc0e86fe4c/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C%2528%253DO%2529N1CCC2%2528CC2%2529C1.png)
![Chemical structure of 1-[2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]azetidine - CSSB02519442990](/st/structure/200/7cf968aa3cb2cd8cc748ef15417a3790/CC1%253DCC%253DC%2528C%253DC1C%2528%253DO%2529N1CCC1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
